期刊文献+

系统性红斑狼疮外周血单个核细胞周期相改变及药物影响 被引量:3

Cell Cycle-Phase and It's Changes of Peripheral Blood Mononuclear Cells in Patients with Systemic Lupus Erythematosus
下载PDF
导出
摘要 【目的】研究系统性红斑狼疮(systemic lupus erythematosus SLE)外周血单个核细胞(peripheral bloodmononuclear cells PBMCs)的细胞周期相改变和药物的影响,探讨其在SLE发病中的作用。【方法】用流式细胞分析技术,检测SLE患者(活动期和静止期)PBMCs的细胞时相构成比例,观察药物对其的影响,并和正常人进行比较;分析SLE患者细胞周期时相构成比例和血清抗dsDNA抗体的相关性.【结果】①基础状况下,SLE患者PBM-Cs的细胞周期时相构成比例(%)和正常人之间无明显差别(均P>0.05)。②植物凝集素(phytohemagglutinin,PHA)使活动期SLE患者PBMCs的G_0/G_1期比例减低(P<0.01)和S期比例增高(P<0.01)、缓解期SLE患者PBMCs S期比例增高(P<0.01)、正常人PBMCs各时相均无明显改变。③用地塞米松(dexamethasone,Dex)后,活动期SLE患者PBMCs各期时相比例无改变,缓解期SLE患者PBMCs G_0/G_1期比例增高(P<0.001)和S期比例减低(P<0.001),正常人PBMCs的G_0/G_1期比例增高(P<0.05)。④活动期SLE患者血清抗dsDNA抗体和G_0/G_1期比例呈负相关(r=-0.787,P=0.001)、和S期比例呈正相关(r=0.855,P=0.0001)。【结论】SLE患者PBMCs具有较强的潜在增殖活性,其时相构成比例和血清抗dsDNA抗体相关,可能和其发病及病程有关。 [ Objective ] To investigate the changes of cell cycle-phase of peripheral blood mononu-clear cells (PBMCs) in patients with systemic lupus erythematosus (SLE) and the effects of all changes by drugs. [Methods] The constituent ratio of different cell cycle-phase of PBMCs in patients with active and inactive SLE and health control were examined by flow cytometric analysis. After stimulated by phytohemagglutinin (PHA) and depressed by dexamethasone (Dex), these examinations were repeated. The correlation between constituent ratio of different cell cycle-phrase of PBMCs and serum anti-dsDNA antibody level were analysed. [Results] (1) There were no significant difference at the constituent ratio of different cell cycle-phase of PBMCs in SLE and health control at basal status. (2) Stimulated by PHA, the constituent ratio of phase Go/G1 of PBMCs decreased markedly in active SLE ( P < 0. 01), the phase S increased in active and inactive SLE (all P < 0. 01), and there were no changes of PBMCs in health control. (3) Depressed by Dex, the constituent ratio of phase Go/Gi of PBMCs increased significant in inactive SLE ( P < 0. 001) and health control ( P < 0. 05), the phase S decreased in inactive SLE (P < 0. 001), and there were no changes of PBMCs in active SLE. (4) In patients with active SLE, there were negative correlation between anti-dsDNA antibody level and constituent ratio of phase G0/G1( P = 0. 001), there were positive correlation between an-ti-dsDNA antibody level and constituent ratio of phase S( P = 0.0001). [Conclusion] There were strong latent proliferation activity of PBMCs in patients with SLE and correlation between constituent ratio of different cell cycle-phrase of PBMCs and serum anti-dsDNA antibody level. These may be related to the pathaeenesis etiology and the course of SLE.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2003年第3期274-276,294,共4页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省医学科学研究基金(2001151) 中山医科大学"211工程"重点科研基金(98151)
关键词 系统性红斑狼疮 外周血 单个核细胞 细胞周期 流式细胞技术 lupus erythematosus, systemic flow cytometry cell cycle
  • 相关文献

参考文献9

  • 1Dorner T, Putterman C.B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus[J].Arthritis Res,2001,3 (4):197.
  • 2Pagama M.Cell cycle- material and methods[M].Berlin: Springer- Verlag Berlin Heidelberg, 1996, 5~ 20.
  • 3Tan E M, Cohen A S, Fries J F, et al.The 1982 revised criteria for the classification of systemic lupus erythematosus[J].Arthritis Rheum,1982,25 (11):1271.
  • 4Bombardier C, Gladman D D, Urowitz M B, et al.Derivation of the SLEDAI: a disease activity index for lupus patients[J].Arthritis Rheum,1992,35 (6):630.
  • 5Michel M C, van Tits L J, Trenn G, et al.Dissociation between phytohaemaggtutinin- stimulated generation of inosital phosphates and Ca2+ increase in human mononuclear leucocytes [J].Biochem J,1992,285 (1):137.
  • 6Grousson J, Ffrench M, Concha M, et al.CD40 ligation alters the cell cycle of differentiating keratinocytes[J].J Invest Dermatol,2000,114 (3):581.
  • 7Reil T D, Kashyap V S, Sarker R, et al.Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation [J].J Surg Res, 2000,92 (1):108.
  • 8Terada Y, Okado T, Inoshita S, et al.Glucocorticoids stimulate p21CIP1 in mesangial cells and in anti- GBM glomerulonephritis[J].Kidney Int,2001,59 (5):1706.
  • 9Arbuckle M R, James J A, Kohlhase K F, et al.Development of anti- dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus[J].Scand J Immunol,2001, 54(1- 2): 211.

同被引文献31

  • 1李幼姬 叶任高 等.红细胞活体染色后用光镜鉴别血尿来源的新方法[J].中华肾脏病杂志,1985,1(2):74-76.
  • 2Yang N, Isbel N, Nikolic-Paterson D J, et al. Local macrophage proliferation in human glomerulonephritis[J]. Kidney Int, 1998,54( 1 ) : 143.
  • 3陈晓岚 叶任高 杨念生 等.老年性狼疮性肾炎30例临床特点.中国老年病杂志,1997,17:151-151.
  • 4Ling SH,Ye RG. Increansed serum and urine levels of soloble interleukin-2 receptor in active lupus nephrotis[J]. J Am Soc Nephrol, 1993,4(3):292.
  • 5Salaman MR.A two-step hypothesis for the appearance of autoimmune disease[J].Autoimmunity,2003,36(2):57-61.
  • 6Sakaguchi S.Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses[J].Annu Rev Immunol,2004,22(8):531-562.
  • 7Shull MM,Ormsby I,Kier AB,et al.Targeted disruption of the meuse transforming growth factor-beta 1 gene results in multifocal inflammatory disease[J].Nature,1992,359 (6397):693-699.
  • 8Ohtsuka K,Gray JD,Stimmler MM,et al.The relationship between defects in lymphocyte production of transforming growth factor-beta1 in systemic lupus erythematosus and disease activity or severity[J].Lupus,1999,8(2):90-94.
  • 9Liu MF,Wang CR,Fung LL,et al.Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus[J].Scand J lmmunol,2004,59(2):198-202.
  • 10Lee JH,Wang LC,Lin YT,et al.Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus[J].Immunology,2006,117(2):280-286.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部